Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001193125-15-138437
Filing Date
2015-04-20
Accepted
2015-04-20 17:28:41
Documents
15
Period of Report
2015-06-19

Document Format Files

Seq Description Document Type Size
1 PRE 14A d910154dpre14a.htm PRE 14A 477692
2 GRAPHIC g910154g37a73.jpg GRAPHIC 133227
3 GRAPHIC g910154g51a38.jpg GRAPHIC 132186
4 GRAPHIC g910154g79v24.jpg GRAPHIC 2912
5 GRAPHIC g910154line.jpg GRAPHIC 441
6 GRAPHIC g910154p1.jpg GRAPHIC 264884
7 GRAPHIC g910154p2.jpg GRAPHIC 131737
8 GRAPHIC g910154tx_pg1.jpg GRAPHIC 106260
9 GRAPHIC g910154tx_pg2.jpg GRAPHIC 118260
10 GRAPHIC g910154tx_pg3.jpg GRAPHIC 167484
11 GRAPHIC g910154tx_pg4a.jpg GRAPHIC 7885
12 GRAPHIC g910154tx_pg4b.jpg GRAPHIC 5126
13 GRAPHIC g910154tx_pg6a.jpg GRAPHIC 3836
14 GRAPHIC g910154tx_pg6b.jpg GRAPHIC 1722
15 GRAPHIC g910154tx_pg6c.jpg GRAPHIC 2552
  Complete submission text file 0001193125-15-138437.txt   1967052
Mailing Address 4640 SW MACADAM AVENUE SUITE 270 PORTLAND OR 97239
Business Address 4640 SW MACADAM AVENUE SUITE 270 PORTLAND OR 97239 855 855 GALE
Galena Biopharma, Inc. (Filer) CIK: 0001390478 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-33958 | Film No.: 15781392
SIC: 2834 Pharmaceutical Preparations